LISA CORWIN: Open Payments
NPI 1740479757 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 12 payments from 3 companies in 2025. Trend: 2023 $352 · 2024 $85 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $14 |
Products named: XIFAXAN, REXULTI.
Industry payments across MO — which companies pay providers there.
